CFTR and cystic fibrosis: In contrast for cystic fibrosis, activation of TMEM16A on the apical membrane of epithelial cells has been proposed as one strategy to bypass the CFTR chloride secretory defect to improve hydration and mucociliary clearance, but bronchoconstriction and pain have been pointed out as possible unwanted side effects (Sondo et al., 2014; Liu et al., 2016).